Gengmei is a mobile-based platform providing information, social networking, and e-commerce channels for medical aesthetics and cosmetic surgery.
German Medical Technologies is a growth-stage medical device company focused on developing, manufacturing, and marketing medical consumables.
IMHealthcare (IMH) is a provider of medical care clinics for both corporate clients and China’s industrial parks.
InnoCare is a biopharmaceutical company in China with the global vision to discover and develop novel treatment for cancer and autoimmune diseases.
Jingfeng Pharmaceuticals (SZ: 000908) is a leading Chinese specialty pharmaceutical company.
Omni Pharma is a leading pharmaceutical company specializing in developing and manufacturing high quality inhalation pharmaceutical products in China. The Company has established the most advanced inhalation formulation platform.
PrinJohnson BioPharm focuses on the development and sale of generic pharmaceuticals.
SinoMedCare Biotech is a leading, innovation-driven pharmaceutical distribution platform.
Terns Pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver disease and cancer.
TGS Medical (Golden Stapler) is a medical device company dedicated to R&D, manufacture, and commercialization of instruments used in traditional and minimally-invasive surgical procedures.
TOT Biopharm is a biopharmaceutical enterprise dedicated to developing, manufacturing, and commercializing oncology drugs.
VISEN Pharma – Developing and commercializing TransCon hGH, TransCon PTH, and TransCon CNP for the Greater China market.
WuXi AppTec (NYSE: WX) is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with operations in China and the United States.
Yichuan NasAroma specializes in research & development of nasal delivery system products based on aromatherapy and traditional Chinese herb medicine.
Zai Lab is a Shanghai-based biopharmaceutical company. Our globally-experienced drug development team is passionate about bringing transformative medicines to China and discovering and developing our own therapeutics for patients worldwide.

Privately held companies at the time of Vivo’s initial investment.